We have shown in this study that, in a cohort of patients residing in the same region and whose tumor specimens were analyzed in the same laboratory, there is likely no racial difference in KRAS mutation frequency, but there is likely a significant racial difference in BRAF mutation frequency. This evidence concerns the gene BRAF and neoplasm.